id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-F-0821-0002,FDA,FDA-2016-F-0821,"Listing of Color Additives Exempt From Certification; Titanium Dioxide
and Listing of Color Additives Subject to Certification; [Phthalocyaninato (2-)] Copper",Rule,Direct Final Rule,2016-11-01T04:00:00Z,2016,11,2016-11-01T04:00:00Z,2016-12-02T04:59:59Z,2016-12-02T02:00:29Z,2016-26310,0,0,090000648236253f
FDA-2016-F-0821-0003,FDA,FDA-2016-F-0821,"Reference 1 Memorandum from H. Lee, Division of Petition Review, Chemistry Review Team, to P. DeLeo, Division of Petition Review, Regulatory Group I, FDA, March 1, 2005 re Listing of Color Additives Exempt From Certification; Titanium Dioxide and Listing of Color Additives Subject to Certification; [Phthalocyaninato (2-)] Copper",Supporting & Related Material,Background Material,2016-11-01T04:00:00Z,2016,11,,,2016-11-01T19:24:15Z,,0,0,0900006482364919
FDA-2016-F-0821-0004,FDA,FDA-2016-F-0821,"Reference 2 Memorandum from H. Lee, Division of Petition Review, Chemistry Review Team, to L. Dye, Division of Petition Review, Regulatory Group I, FDA, April 20, 2016 re Listing of Color Additives Exempt From Certification; Titanium Dioxide and Listing of Color Additives Subject to Certification; [Phthalocyaninato (2-)] Copper",Supporting & Related Material,Background Material,2016-11-01T04:00:00Z,2016,11,,,2016-11-01T19:26:22Z,,0,0,090000648236491c
FDA-2016-F-0821-0005,FDA,FDA-2016-F-0821,"Reference 3 Memorandum from Y. Zang, Division of Petition Review, Toxicology Review Team, to L. Dye, Division of Petition Review, Regulatory Group I, FDA, June 30, 2016 re Listing of Color Additives Exempt From Certification; Titanium Dioxide and Listing of Color Additives Subject to Certification; [Phthalocyaninato (2-)] Copper",Supporting & Related Material,Background Material,2016-11-01T04:00:00Z,2016,11,,,2016-11-01T19:28:18Z,,0,0,090000648236495c
FDA-2016-F-0821-0001,FDA,FDA-2016-F-0821,"Milton W. Chu, M.D.; Filing of Color Additive Petition",Proposed Rule,Petition,2016-03-22T04:00:00Z,2016,3,2016-03-22T04:00:00Z,,2016-03-22T13:16:05Z,2016-06397,0,0,0900006481ed5ea7